• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

西非针对脑膜炎球菌性脑膜炎开展预防性和反应性大规模免疫接种运动的成本效益比较:一项理论模型分析

Comparison of cost-effectiveness of preventive and reactive mass immunization campaigns against meningococcal meningitis in West Africa: a theoretical modeling analysis.

作者信息

Parent du Châtelet I, Gessner B D, da Silva A

机构信息

Association pour l'Aide à la Médecine Préventive, 28 rue du Docteur Roux, 75724 Cedex 15, Paris, France.

出版信息

Vaccine. 2001 May 14;19(25-26):3420-31. doi: 10.1016/s0264-410x(01)00066-4.

DOI:10.1016/s0264-410x(01)00066-4
PMID:11348706
Abstract

For epidemic meningitis control in sub-Saharan Africa, the World Health Organization recommends a strategy of emergency vaccination with meningococcal A + C polysaccharide vaccine when epidemic thresholds are exceeded. An alternative strategy for areas without effective surveillance systems is mass preventive campaigns before outbreaks occur. A model was formulated to simulate epidemics and to compare the cost-effectiveness of these two strategies for the district of Matam, Senegal, where an actual preventive campaign was performed during 1997. The preventive strategy prevented 59% of the cases compared to 49% for the emergency strategy. The cost per case prevented was US$59 for the preventive strategy and US$133 for the reactive strategy, and the preventive strategy saved US$0.20 per habitant. Preventive meningococcal vaccination through mass campaigns prevented more outcomes at a lower cost, provided that the occurrence of an epidemic could be predicted within 3 years and that the vaccination coverage rates for the preventive and standard strategies were > 70% and < 94%, respectively. Sub-Saharan African countries without effective surveillance systems should consider mass preventive campaigns while awaiting an affordable conjugate vaccine.

摘要

为控制撒哈拉以南非洲地区的流行性脑膜炎,世界卫生组织建议,当超过流行阈值时,采用A + C群脑膜炎球菌多糖疫苗进行应急接种的策略。对于没有有效监测系统的地区,另一种策略是在疫情爆发前开展大规模预防接种活动。我们建立了一个模型来模拟疫情,并比较这两种策略在塞内加尔马塔姆地区的成本效益,该地区在1997年开展了一次实际的预防接种活动。预防策略预防了59%的病例,而应急策略为49%。预防策略每预防一例病例的成本为59美元,反应性策略为133美元,预防策略每位居民节省0.20美元。如果能在3年内预测到疫情的发生,且预防策略和标准策略的疫苗接种覆盖率分别> 70%和< 94%,那么通过大规模预防接种活动进行预防性脑膜炎球菌疫苗接种可以以更低的成本预防更多的病例。在等待可负担得起的结合疫苗期间,没有有效监测系统的撒哈拉以南非洲国家应考虑开展大规模预防接种活动。

相似文献

1
Comparison of cost-effectiveness of preventive and reactive mass immunization campaigns against meningococcal meningitis in West Africa: a theoretical modeling analysis.西非针对脑膜炎球菌性脑膜炎开展预防性和反应性大规模免疫接种运动的成本效益比较:一项理论模型分析
Vaccine. 2001 May 14;19(25-26):3420-31. doi: 10.1016/s0264-410x(01)00066-4.
2
[Microeconomic evaluation of a mass preventive immunisation campaign against meningococcal meningitis and yellow fever in Senegal in 1997].[1997年塞内加尔针对脑膜炎球菌性脑膜炎和黄热病开展大规模预防性免疫接种运动的微观经济评估]
Sante. 2003 Oct-Dec;13(4):215-23.
3
Emergency vaccination against epidemic meningitis in Ghana: implications for the control of meningococcal disease in West Africa.加纳针对流行性脑膜炎的应急疫苗接种:对西非脑膜炎球菌病控制的影响
Lancet. 2000 Jan 1;355(9197):30-3. doi: 10.1016/S0140-6736(99)03366-8.
4
Review of the cost effectiveness of immunisation strategies for the control of epidemic meningococcal meningitis.控制流行性脑膜炎球菌性脑膜炎免疫策略的成本效益综述
Pharmacoeconomics. 2005;23(4):333-43. doi: 10.2165/00019053-200523040-00004.
5
Economics of an adolescent meningococcal conjugate vaccination catch-up campaign in the United States.美国青少年脑膜炎球菌结合疫苗补种活动的经济学分析
Clin Infect Dis. 2008 Jan 1;46(1):1-13. doi: 10.1086/524041.
6
[An epidemic of meningococcal meningitis in the region of Savanes in Togo in 1997: research and control strategies].[1997年多哥萨瓦内地区的脑膜炎球菌性脑膜炎疫情:研究与控制策略]
Sante. 1997 Nov-Dec;7(6):384-90.
7
Cost-Effectiveness of Alternative Uses of Polyvalent Meningococcal Vaccines in Niger: An Agent-Based Transmission Modeling Study.尼日尔多价脑膜炎球菌疫苗替代用途的成本效益:基于代理的传播建模研究。
Med Decis Making. 2019 Jul;39(5):553-567. doi: 10.1177/0272989X19859899. Epub 2019 Jul 3.
8
Evaluation of meningococcal meningitis vaccination strategies for the meningitis belt in Africa.非洲脑膜炎带地区脑膜炎球菌性脑膜炎疫苗接种策略评估
Pediatr Infect Dis J. 1999 Dec;18(12):1051-9. doi: 10.1097/00006454-199912000-00005.
9
A critical review of control strategies against meningococcal meningitis epidemics in sub-Saharan African countries.
Infection. 2002 Aug;30(4):216-24. doi: 10.1007/s15010-002-3012-2.
10
[Critical review of control strategies for meningococcal meningitis epidemics in Sub-Saharan Africa].[撒哈拉以南非洲地区脑膜炎球菌性脑膜炎流行控制策略的批判性综述]
Bull Soc Pathol Exot. 2002 Mar;95(1):37-44.

引用本文的文献

1
Economic evaluation on meningococcal vaccination strategies among children under nine years of age in Zhejiang province, China.中国浙江省 9 岁以下儿童脑膜炎球菌疫苗接种策略的经济评价。
PLoS One. 2024 Sep 9;19(9):e0310274. doi: 10.1371/journal.pone.0310274. eCollection 2024.
2
Cost-effectiveness analysis of vaccination strategies against meningococcal disease for children under nine years of age in China.中国 9 岁以下儿童接种脑膜炎球菌疫苗的成本效益分析。
Hum Vaccin Immunother. 2024 Dec 31;20(1):2313872. doi: 10.1080/21645515.2024.2313872. Epub 2024 Feb 13.
3
A Systematic Review of the Incremental Costs of Implementing a New Vaccine in the Expanded Program of Immunization in Sub-Saharan Africa.
撒哈拉以南非洲地区扩大免疫规划中实施新疫苗的增量成本的系统评价
MDM Policy Pract. 2019 Dec 19;4(2):2381468319894546. doi: 10.1177/2381468319894546. eCollection 2019 Jul-Dec.
4
Challenges and opportunities for meningococcal vaccination in the developing world.发展中国家脑膜炎球菌疫苗接种的挑战与机遇。
Hum Vaccin Immunother. 2018 May 4;14(5):1084-1097. doi: 10.1080/21645515.2018.1434463. Epub 2018 Feb 23.
5
The cost-effectiveness of alternative vaccination strategies for polyvalent meningococcal vaccines in Burkina Faso: A transmission dynamic modeling study.多价脑膜炎球菌疫苗替代接种策略在布基纳法索的成本效益:基于传播动力学模型的研究。
PLoS Med. 2018 Jan 24;15(1):e1002495. doi: 10.1371/journal.pmed.1002495. eCollection 2018 Jan.
6
Modeling the cost-effectiveness of the integrated disease surveillance and response (IDSR) system: meningitis in Burkina Faso.建模综合疾病监测和应对(IDSR)系统的成本效益:布基纳法索脑膜炎。
PLoS One. 2010 Sep 28;5(9):e13044. doi: 10.1371/journal.pone.0013044.
7
Cost analysis of an integrated disease surveillance and response system: case of Burkina Faso, Eritrea, and Mali.综合疾病监测和应对系统的成本分析:以布基纳法索、厄立特里亚和马里为例。
Cost Eff Resour Alloc. 2009 Jan 8;7:1. doi: 10.1186/1478-7547-7-1.
8
Review of the cost effectiveness of immunisation strategies for the control of epidemic meningococcal meningitis.控制流行性脑膜炎球菌性脑膜炎免疫策略的成本效益综述
Pharmacoeconomics. 2005;23(4):333-43. doi: 10.2165/00019053-200523040-00004.
9
Cost-benefit model comparing two alternative immunisation programmes against serogroup C meningococcal disease: for Quebec residents aged 2 months to 20 years.
Pharmacoeconomics. 2003;21(6):429-42. doi: 10.2165/00019053-200321060-00006.